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a b s t r a c t
In this article we investigate the role of anisotropic diffusion on the resulting arterial wall drug distribu-
tion following stent-based delivery. The arterial wall is known to exhibit anisotropic diffusive properties,
yet many authors neglect this, and it is unclear what effect this simplification has on the resulting arterial
wall drug concentrations. Firstly, we explore the justification for neglecting the curvature of the
cylindrical arterial wall in favour of using a Cartesian coordinate system. We then proceed to consider
three separate transport regimes (convection dominated, diffusion dominated, reaction dominated)
based on the range of parameter values available in the literature. By comparing the results of a simple
one-dimensional model with those of a fully three-dimensional numerical model, we demonstrate,
perhaps surprisingly, that the anisotropic diffusion can promote the spatial uniformity of drug concentra-
tions, and furthermore, that the simple analytical one-dimensional model is an excellent predictor of the
three-dimensional numerical results. However, the level of uniformity and the time taken to reach a
uniform concentration profile depends on the particular regime considered. Furthermore, the more
uniform the profile, the better the agreement between the one-dimensional and three-dimensional
models. We discuss the potential implications in clinical practice and in stent design.
 2015 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).
1. Introduction
Local drug delivery to the arterial wall is becoming an increas-
ingly common method of tackling restenosis (re-narrowing of the
lumen) following percutaneous coronary interventions (PCIs).
These PCIs, commonly known as angioplasty, are non-surgical
procedures used to treat narrowed arteries as a result of coronary
heart disease (CHD). The most common of these PCIs is the
insertion of a small mesh-like device called a stent [1], to act as a
scaffold and widen the lumen. Some of the methods of reducing
restenosis include directly coating the stent with a drug (the
so-called drug-eluting stent) and, more recently, by inflating a
drug-coated balloon at the required site [2,3]. Modelling the
transport of drug from the device through the arterial wall is
extremely challenging given the multitude of factors that influence
drug distribution. For example, a portion of drug will likely be
carried away by the pulsatile flowing blood in the lumen and the
drug that enters the arterial wall is subject to diffusion, convection
and binding, while at the same time the artery is under the
influence of contraction and relaxation. To complicate matters
further, the arterial wall is a heterogeneous structure, consisting
of three distinct layers with possibly different anisotropic proper-
ties in each layer. Notwithstanding, many models of differing
dimensionality and different simplifying assumptions have been
proposed for modelling the transport through these tissue layers.
These models have emanated from the substantial body of work
on mass transport in biological tissue which has featured heavily
in the literature over the past few decades. We refer the interested
reader to the review by Khaled and Vafai [4] for background
reading and to the recent work by the same group [5] on mass
transport in mammary glands which is an excellent exemplar of
a different application of mass transport in biological tissue.
Whilst some authors explicitly account for the curvature of the
arterial wall (see e.g. [3]), in the literature it is standard to neglect
the curvature so that the resulting model may be written in a
Cartesian coordinate framework (see e.g. [6–8]). However, this
assumption is never justified mathematically. Tzafriri et al. [7]
did, however, state that they had carried out numerical simulations
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which illustrated that maximal tissue drug content was 10%
lower when neglecting the curvature dependent term. However,
this was for a specific set of parameter values. Another common
simplification is to treat the arterial wall as a single layer with
uni-directional convection and isotropic diffusion properties (see
[7,9–12] among others). Coupled with the negligible curvature
assumption, this allows the transport equation in the arterial wall
to be written in one-dimension as
@C
@t
þ v
@C
@x
¼ D
@2C
@x2
 R; ð1:1Þ
where C is the volume-averaged concentration of drug in the
arterial wall, v is the magnitude of the transmural convection, D
is the diffusion coefficient of drug within the tissue and R is some
reaction term to account for the effects of binding. A variety of
models for R have been reported (see [1] for a review of these).
However, there exists experimental evidence that within each layer
anisotropy may be important. For example, diffusion within the tis-
sue has been reported to be anisotropic [13,14] with the diffusion
coefficient in the radial direction at least 10 times (and possibly
as much as 100 or 1000 times) less than that in the circumferential
and axial directions. This anisotropy cannot be captured by a
one-dimensional model and it is unclear the effect this simplifica-
tion has on the resulting concentration profiles.
Realising this, many authors have turned to higher dimensional
models. For example, [15,8] both considered a two-dimensional
model in a Cartesian geometry, and [16] proposed a two-
dimensional model in a cylindrical co-ordinate system. The focus
of the work in [15] was on the difference in the transport proper-
ties of two commercially available drugs (paclitaxel and sirolimus)
and how this can affect the distribution of drug in the arterial wall,
while [16] focussed on the influence of strut compression on the
drug transport properties of the arterial wall. Zhu et al. [8], on
the other hand, were more concerned with the effect of diffusion
(in their two-dimensional model) on the resulting arterial wall
drug levels. In each case, anisotropic diffusion coefficients were
accounted for, with the diffusion coefficient in the radial direction
chosen to be different from that in the circumferential direction.
Being two-dimensional, these models were unable to study the
effect of a different diffusion coefficient in each of the three
mutually perpendicular directions.
Weiler et al. [17] provided a broad generalization of the works
of [18–20]: a three-dimensional model of drug transport in the
lumen and the arterial wall. However, only the steady diffusion
equation (no time-dependence, convection nor reaction) was
considered in the arterial wall and drug diffusion was assumed
to be isotropic. Horner et al. [21] appear to be one of the first
groups to provide a three-dimensional reaction–diffusion–convec
tion model in a realistic geometry (obtained using ABAQUS soft-
ware). Whilst having the advantage of allowing for a variation in
the diffusion coefficient in three spatial directions, the authors only
considered the case in which the axial and circumferential diffu-
sion coefficients were the same. They also make a number of signif-
icant simplifications. Perhaps the most unrealistic assumption is
that of a constant drug source: the drug concentration on the stent
remains constant and does not deplete.
Whilst not explicitly considering anisotropic diffusion, Saylor
et al. [22] most recently attempted to better account for the
structure of the arterial wall by presenting a structure-sensitive
continuummodel of arterial drug deposition. Their model attempts
to account explicitly for variations in tissue structure, and they are
able to derive a closed form analytical solution of their
one-dimensional model, after making some simplifying assump-
tions. Using their analytical expression, they fit for the unknown
material parameters in the model based on ex-vivo experimental
data, and they found that the data were well fit by the model.
In this paper, we investigate the role of anisotropic diffusion on
the resulting arterial wall drug distribution following stent-based
delivery. We start by exploring the justification for neglecting the
arterial curvature before investigating the impact of the transport
regime (convection dominated, diffusion dominated, reaction
dominated) on the uniformity of drug concentrations in the
abluminal-facing plane. In this context, the word ‘‘uniformity’’
should be interpreted loosely as the closeness of the numerical
drug concentration values in the abluminal-facing plane: the more
uniform the drug concentrations are, then the closer their differ-
ence is to zero. We then proceed to compare drug concentrations
obtained from a one-dimensional model with those from the cor-
responding three-dimensional anisotropic model. Analytical solu-
tions are derived for the one-dimensional model and the open
source computational software openFoam is utilised to compute
the three dimensional solution. We conclude by providing recom-
mendations for when a one-dimensional model may reasonably be
used and, further, we comment on stent design (in terms of strut
thickness and strut spacing) based on our findings and desired
clinical outcome.
Nomenclature
a arterial inner radius
b arterial outer radius
c volume averaged drug concentration
c0 initial stent drug concentration
D radial diffusion coefficient
D1 axial/circumferential diffusion coefficient
Da1 non-dimensional first Damkohler number
Da2 non-dimensional second Damkohler number
K drug absorption rate
L arterial wall thickness
L1 half strut separation
L2 half strut thickness
r cylindrical radial coordinate
Pe non-dimensional Peclet number
R reaction term
t time
T non-dimensional time
v magnitude of transmural velocity
x Cartesian spatial coordinate
X non-dimensional spatial coordinate
y Cartesian spatial coordinate
Y non-dimensional spatial coordinate
z Cartesian/cylindrical spatial coordinate
Z non-dimensional spatial coordinate
a ratio of arterial wall thickness to half-strut separation
c ratio of radial to axial diffusion coefficient
C computational domain
C1 drug containing region of abluminal facing plane
C2 drug containing region of abluminal facing plane
C3 drug-free region of abluminal facing plane
 ratio of arterial wall thickness to arterial radius
h cylindrical circumferential coordinate
hH wedge angle with abluminal-facing arc length equal to
the half strut separation
k drug release rate
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2. The mathematical models
Before setting down the models, we specify the simplifying
assumptions that are to be made. Firstly, since the focus of this
research is to investigate the effect of anisotropic diffusion on drug
distribution in the tissue, we do not model the release of drug from
the device. Instead, we assume that the drug concentration at the
boundary between the lumen and the arterial wall may be
described by an exponentially decaying function of time [24,25].
Secondly, we impose zero-flux conditions on the lumen/tissue
interface and zero concentration on the exterior of the arterial wall.
In the in vivo scenario, Robin type conditions are likely to be more
appropriate in both cases: a fraction of drug will be washed away
by the blood flow; and, while the drug concentration at the exte-
rior of the tissue may be small, it is unlikely to be identically zero.
However, the drug lost to the blood could be accounted for in the
exponentially decaying boundary condition at the lumen, and all of
the boundary conditions assumed here may, in principle, be main-
tained in ex-vivo experiments. Thirdly, we assume as is standard in
the literature, that convection is uni-directional and acts radially
due to the pressure difference across the arterial wall. We make
the further reasonable and common assumption that the diffusion
coefficients and reaction parameters in the arterial wall are
independent of space, concentration and time.
Stent manufacturers are predominantly concerned with the
mechanical integrity of the device and as such the stent design is
usually the first consideration. The stent must be flexible and
expandable and stay in situ after deployment. During the expan-
sion process the stent should undergo minimum shortening and
after implantation should conform to the natural geometry of the
vessel without any unnatural straightening. Circumferential
strength is another key component; without this, the stent will col-
lapse under the strain of the artery. A wide variety of stent designs
are currently available and despite their sometimes complex
appearance, they are designed to have a regular structure. If the
stent is ‘flattened out’ (or ‘unwrapped’) then there is usually a clear
repeating ‘unit cell’. These unit cells are separated by connectors to
enhance the flexibility and conformability. For the purposes of this
paper, we consider an idealised stent geometry exhibiting equally
spaced struts and a regular structure, with the unit cell taking the
form of a square (see Fig. 1 for a portion of the stent). In many cur-
rently available stents, the unit cell takes the form of a diamond,
from which our unit cell can be seen to be a special case.
Now, consider a drug-eluting stent with idealized strut geome-
try as displayed in Fig. 1. When placed inside the artery, we assume
that the struts impinge upon (but do not penetrate into) arterial
tissue. Because of the symmetry of the problem, we need only con-
sider a portion of the cylinder, a wedge, as shown in Fig. 1. Now
consider the typical section shaded red in Fig. 1. It is readily seen
that our computational domain need only comprise one quarter
of the region bounded by the blue box, with zero flux conditions
being applied along the lines of symmetry. This significantly
reduces the computational burden.
2.1. Justification for using a Cartesian system
The equation of drug transport in the arterial wall is stated in a
cylindrical co-ordinate system as:
@c
@t
þ v
@c
@r
¼ D
@2c
@r2
þ
1
r
@c
@r
 !
þ D1
1
r2
@2c
@h2
þ
@2c
@z2
 !
 Kc;
a < r < b; 0 < h < hH; 0 < z < L1; ð2:1Þ
where c ¼ cðr; h; z; tÞ is the volume averaged concentration of drug
in the tissue of thickness ðb aÞ and the parameters v and K repre-
sent the magnitude of the transmural velocity and the absorption
rate of drug within the system (for example to smooth muscle cells,
interstitial tissue or through vasa vasorum sinks). We assume that
the diffusion coefficient of the drug in the radial direction, D, is dif-
ferent from that in the circumferential and axial directions, D1. The
parameter L1 is the half strut separation as shown in Fig. 1 and h
H is
the angle of the wedge which gives rise to an abluminal-facing arc
length of L1. Let us introduce the non-dimensional variables
T ¼ Dt=ðb aÞ
2
; X ¼ ðr  aÞ=ðb aÞ; C ¼ c=c0;
Y ¼ h=hH; Z ¼ z=L1;
where c0 is the initial drug concentration on the stent. Then (2.1)
becomes
@C
@T
þ Pe
@C
@X
¼
@2C
@X2
þ

1þ X
@C
@X
þ
1
hH
2
c

1þ X
 2
@2C
@Y2
þ
a2
c
@2C
@Z2
 Da2C; 0 < X < 1; 0 < Y < 1; 0 < Z < 1; ð2:2Þ
where Pe ¼ vðb aÞ=D and Da2 ¼ Kðb aÞ
2
=D are the Peclet
number and second Damkohler number, respectively, and
c ¼ D=D1;  ¼ ðb aÞ=a and a ¼ ðb aÞ=L1:
We note that , the ratio of arterial wall thickness to arterial radius,
is typically small. Thus we may write

1þ X
¼ OðÞ:
Furthermore, by trigonometric arguments, for hH small, hH  L1=a.
Taking these together, the factor multiplying the second derivative
with respect to Y can be approximated by
1
hH
2
c

1þ X
 2

a2
c
:
Thus we may write (2.2) as
@C
@T
þ Pe
@C
@X

@2C
@X2
þ 
@C
@X
þ
a2
c
@2C
@Y2
þ
@2C
@Z2
 !
 Da2C;
0 < X < 1; 0 < Y < 1; 0 < Z < 1: ð2:3Þ
Fig. 1. Schematic showing the geometry of the problem. The inner radius is denoted
by a while the outer radius is denoted by b. The arterial wall is represented by b a.
We need only consider a portion of this domain, where h controls the number of
struts to be included in the computation. The strut separation is denoted 2L1 while
the strut thickness is 2L2. In practice our computational domain comprises one
quarter of the region bounded by the blue box and we apply zero flux conditions
along the lines of symmetry.
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It is now evident that if  1 and  a2=c, then the term which
arises as a result of the cylindrical coordinate system is negligible
and we may write
@C
@T
þ Pe
@C
@X

@2C
@X2
þ
a2
c
@2C
@Y2
þ
@2C
@Z2
 !
 Da2C;
0 < X < 1; 0 < Y < 1; 0 < Z < 1; ð2:4Þ
which is essentially the equation for transport in a rectangular
co-ordinate system. In addition, if Pe 1 then the convection term
is negligible compared with diffusion and, further, if Da2  1 then
the reaction term is also negligible in comparison with diffusion.
Now, for the system under consideration in this paper, we have that
 ¼ 0:1 and a2=c ¼ 2:0 (see Table 1) and so it is reasonable to
approximate the curved arterial wall geometry as rectangular. We
note that several authors have developed one-dimensional models
which consider drug transport only in the radial direction and
neglect the curvature of the arterial wall, allowing them to utilize
a Cartesian co-ordinate system. For the one-dimensional case we
see immediately from (2.3) that approximating the cylindrical
geometry as rectangular is justified provided that  1.
2.2. Parameter values
For this study we estimated the parameter values based on data
currently available in the literature. In line with the findings by
[14] we assume that the radial diffusion coefficient is at least ten
times smaller than the circumferential and axial diffusion coeffi-
cients and consider a range of values based on [7,15], which satisfy
this condition. The thickness of the tissue and arterial radius are
chosen to be in line with those of a porcine coronary artery [7]
which is the most widely used model due to its anatomical
similarity to the human coronary artery. The magnitude of the
transmural velocity is generally considered to be in the range
108  107 ms1 [7,10]. We choose the stent strut thickness and
separation based on the works of [15]. A representative drug
release rate of 105 s1 is selected [24,25]. Finally, we consider a
range of drug absorption rates covering two orders of magnitude
[21,23]. The values considered are summarised in Table 1.
Many of these parameters are in fact drug-dependent. For
example, the drug diffusion coefficient in the tissue varies
depending on the particular molecule in question and the drug
release rate may be highly dependent on the diffusion of drug
within the stent coating, if indeed the drug is contained within a
coating. Furthermore, the drug absorption rate (and indeed the
binding model) will depend on the binding properties of the partic-
ular drug within the tissue. We note that there is a large degree of
uncertainty in the values reported in the literature. Often these val-
ues have been estimated based on experiments with a small num-
ber of repetitions, and in some cases effective diffusion coefficients
(which inherently include such effects as transmural convection
and binding) are calculated. Furthermore, the transport properties
vary from species to species and may well vary substantially
between tissue samples of the same species. Since we are lacking
a full set of our model parameters for the drugs commonly coated
on drug-eluting stents, we are not able to run drug-specific simu-
lations. However, we do make some comments on specific drugs in
Section 5. The values reported here should be treated as indicative
only and could easily be an order of magnitude higher or lower in
reality. With this in mind, a range of values are considered.
2.3. Three dimensional model
We proceed to solve the three dimensional diffusion–
convection–reaction equation in a rectangular geometry. Without
loss of generality, we solve over the radial region x 2 ð0; LÞ (where
L ¼ b a) rather than x 2 ða; bÞ. The computational domain, C, is
displayed in Fig. 2.
Let us define the following drug-containing regions:
C1 :¼ x ¼ 0; 0 6 y 6 L1; 0 6 z 6 L2f g
C2 :¼ x ¼ 0; 0 6 y 6 L2; L2 < z 6 L1f g:
We denote the initially drug-free region of the y—z plane in contact
with the lumen by C3, where
C3 :¼ x ¼ 0; L2 6 y 6 L1; L2 6 z 6 L1f g:
Then, denoting the volume averaged drug concentration by
cðx; y; z; tÞ and the stent drug decay rate by k, we may write the
model as
Table 1
Table of parameter values.
Parameter Symbol Value References
Arterial inner radius a 5 103 m [7]
Arterial outer radius b 5:5 103 m [7]
Arterial wall thickness L 5 104 m [7]
Axial and circumferential
diffusion coefficient
D1 1011  1010 m2 s1 [7,15]
radial diffusion coefficient D 1012  1011 m2 s1 [7,15]
Half strut separation L1 3:5 104 m [15]
Half strut thickness L2 7:5 105 m [15]
Magnitude of transmural
velocity
v 108  107 m s1 [7,10]
Drug absorption rate K 105  104 s1 [21,23]
Drug release rate k 105 s1 [24,25]
Fig. 2. Schematic of the computational domain, C, displaying the mesh discretiza-
tion. We consider only one quarter of a typical DES cross section with idealized
struts (red) impinged upon arterial tissue (blue). The x; y and z directions represent,
respectively, the radial, circumferential and axial directions. The half strut
separation is L1 , while L2 represents the half strut thickness. The arterial wall
thickness is L. The origin is represented by 0. We refer to the y—z plane as the
abluminal-facing plane. (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
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@c
@t
þ v
@c
@x
¼ D
@2c
@x2
þ D1
@2c
@y2
þ
@2c
@z2
 !
 Kc; t > 0; ð2:5Þ
@c
@x
ð0; y; z; tÞ ¼ 0; ðy; zÞ 2 C3; t > 0; ð2:6Þ
cð0; y; z; tÞ ¼ c0 expfktg; ðy; zÞ 2 C1 [ C2; t P 0; ð2:7Þ
@c
@y
ðx; 0; z; tÞ ¼
@c
@y
ðx; L1; z; tÞ ¼ 0; t > 0; ð2:8Þ
@c
@z
ðx; y;0; tÞ ¼
@c
@z
ðx; y; L1; tÞ ¼ 0; t > 0; ð2:9Þ
cðL; y; z; tÞ ¼ 0; 8 ðy; zÞ; t > 0 ð2:10Þ
cðx; y; z;0Þ ¼ 0 on C n ðC1 [ C2Þ: ð2:11Þ
2.4. One-dimensional model
In the corresponding one-dimensional model we consider only
the radial drug transport, with the diffusion coefficient in the radial
(x) direction given by D. The model in a Cartesian coordinate
system is given by:
@c
@t
ðx;tÞþv
@c
@x
ðx;tÞ¼D
@2c
@x2
ðx;tÞKcðx;tÞ; 0< x< L; t>0; ð2:12Þ
cð0;tÞ¼ c0 exp ktf g; tP0; ð2:13Þ
cðL;tÞ¼0; tP0; ð2:14Þ
cðx;0Þ¼0; 0< x< L: ð2:15Þ
3. Solution of the models
In this section we outline how the three-dimensional and
one-dimensional models are solved. The former is solved numeri-
cally while we adopt an analytical approach to solving the latter.
3.1. Numerical solution of the three-dimensional model
We solve Eqs. (2.5), (2.6), (2.8)–(2.11) numerically using the
finite volume opensource software openFoam [26]. The computa-
tional domain is generated using the openFoam utility
blockMesh. Since we model the drug source as an exponentially
decaying function of time, rather than modelling drug transport
through the stent coating, the radial ‘thickness’ of the blocks repre-
senting the drug filled stent struts was chosen to be sufficiently
small so that they could be considered a surface source. In other
words, for the purposes of the computation, the stent struts are
essentially two-dimensional. Since the strut drug concentration is
taken to be uniform in space, the mesh over regions C1 and C2
was chosen to be quite coarse with 8 cells in each of the y and z
directions. However, we choose a finer mesh on the
abluminal-facing tissue region, C3, consisting of 40 cells in each
of the y and z directions. We select an even finer mesh within
the arterial wall, with 80 cells in the x direction. A mesh sensitivity
study was performed before deciding on this final discretization,
which can be seen in Fig. 2. A time-step study was also conducted
with time-steps of 0:5;30;60;360 and 3600 s considered. For the
chosen mesh, utilizing a time-step of 360 s resulted in less than a
1% difference in the results compared with the 0:5 s time step
and so, to reduce computing time, this time-step was chosen for
the study. The numerical finite volume schemes used to approxi-
mate each of the terms in (2.5) are summarised in Table 2. We refer
the reader to the user documentation [26] for full details on the
schemes employed. The linear solver used to solve each matrix
equation was Preconditioned Bi-Conjugate Gradient (PBiCG) with
a Diagonal Incomplete Lower Upper (DILU) preconditioner. The
solver tolerance was set to 109.
3.2. Analytical solution of the one-dimensional model
We adopt the method of Laplace transformation to solve the
model given by Eqs. (2.12)–(2.15). Taking the Laplace transform
of (2.12), making use of the initial condition (2.15) and rearranging
provides
d
2
c
dx
2
ðx; sÞ 
v
D
dc
dx
ðx; sÞ 
sþ K
D
 
cðx; sÞ ¼ 0: ð3:1Þ
The general solution of (3.1) is
cðx; sÞ ¼ exp
v
2D
x
n o
AðsÞ cosh mðsÞxð Þ þ BðsÞ sinh mðsÞxð Þ½ ; ð3:2Þ
where
2mðsÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v
D
 2
þ
4
D
sþ Kð Þ
r
:
Now, taking Laplace transforms of (2.13) and (2.14) gives rise to
cð0; tÞ ¼
c0
sþ k
; ð3:3Þ
cðL; tÞ ¼ 0: ð3:4Þ
Applying the conditions (3.3) and (3.4) to (3.2) leads to the solution
in Laplace transform space:
cðx; sÞ ¼ 
c0 exp
v
2D
x
 
sinh mðsÞ x Lð Þð Þ
sþ kð Þ sinh mðsÞLð Þ
: ð3:5Þ
Inversion of (3.5) provides the solution. In detail, consider
f ðsÞ ¼
sinh mðsÞ x Lð Þð Þ
sþ kð Þ sinh mðsÞLð Þ
: ð3:6Þ
Now, the complex inversion formula is
f ðtÞ ¼
1
2pi
Z bþi1
bi1
f ðsÞ exp stf gds: ð3:7Þ
The integrand of (3.7) has a simple pole at s ¼ k and infinitely
many simple poles at the roots of sinh mðsÞLð Þ ¼ 0. By series expan-
sion (or otherwise) it is readily observed that there are no branch
points. In practice we evaluate (3.7) using the residue theorem.
The residue at the simple pole s ¼ k is found to be
sinh xL
2D
	 
 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v
2 þ 4DðK  kÞ
p 
exp ktf g
sinh L
2D
	 
 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v
2 þ 4DðK  kÞ
p  : ð3:8Þ
Now, the remaining poles are found by solving
sinh mðsÞLð Þ ¼ 0:
Writing the hyperbolic sine function in terms of exponentials, it is
readily shown that the poles, sn, are given by
sn ¼ 
n2p2D
L2
þ
v
2
4D
þ K
 
; n ¼ 1;2;3; . . .
so that the residue at s ¼ sn is

X1
n¼1
2npD sin npxð Þ exp  n
2p2D
L2
þ v
2
4D
þ K
 
t
n o
L2 k n
2p2D
L2
 v
2
4D
 K
  : ð3:9Þ
Table 2
Summary of the numerical schemes used.
Scheme
Time derivative Crank Nicholson
Gradient Gauss
Divergence Gauss limited linear
Laplacian Gauss linear corrected
Interpolation Linear
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Summing the residues gives f ðtÞ:
f ðtÞ ¼
sinh xL
2D
	 
 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
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2 þ 4DðK  kÞ
p 
exp ktf g
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n o
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2
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  : ð3:10Þ
Returning to (3.5) we see that the solution is given by
cðx; tÞ ¼ 
c0 sinh
xL
2D
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sinh L
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þ
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2
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t
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L2
 v
2
4D
 K
  :
ð3:11Þ
4. Results
In this section we investigate the uniformity of tissue drug con-
centration profiles and at the same time compare the results of the
one-dimensional model with those of the three-dimensional
model. We consider three separate regimes: convection domi-
nated, diffusion dominated and reaction dominated. In addition
to the second Damkohler number (as defined in Section 2), we
introduce the first Damkohler number, Da1 ¼ KL=v , which com-
pares the relative importance of reaction to convection. The
parameter values used for each regime are summarized in Table 3.
4.1. Uniformity of the drug concentrations
We note from Fig. 2 that, due to the geometry under consider-
ation, the two extrema of the drug concentrations in the
abluminal-facing y—z plane will be at the origin, 0, (top left vertex)
and the point (0, L1; L1) (bottom right vertex). It follows that, for all
time, the trajectories P1(x,0,0) and P2(x; L1; L1) will represent the
maximum and minimum drug concentration trajectories through
the arterial wall. Thus, for a given x, the relative difference between
the P1 and P2 concentrations gives a reasonable approximation of
the uniformity of the drug concentration in the y—z plane. In this
context, the word ‘‘uniformity’’ should be interpreted loosely as
the closeness of the numerical drug concentration values: the more
uniform the drug concentrations are then the closer their differ-
ence is to zero.
Initially focussing solely on the three-dimensional model, we
computed drug concentrations for each of the three regimes for
the first 28 days. We found that by 24 h the variation in drug con-
centration with radial distance had assumed a consistent pattern.
That is, beyond 24 h, the profile shape remained the same with
only the concentration values reducing with time. Thus, for all of
our comparisons, we show concentration profiles only over the
first 24 h. Figs. 3–5 display plots of Cðx;0;0Þ and Cðx; L1; L1Þ for
0 < x < L at the times t ¼ 1;3;12 and 24 h. Also displayed on these
plots are the analytical one-dimensional solutions as given by
(3.11). In order to quantify the uniformity, we define an appropri-
ate measure, P1  P2k k, which essentially computes the difference
in drug mass per unit area between P1 and P2 as calculated from
the 3D model, normalized by the drug mass per unit area as
calculated from the 1D model (Eq. 3.11):
P1  P2k k ¼
R L
0
c3Dðx;0;0; tÞdx
R L
0
c3Dðx; L1; L1; tÞdxR L
0
c1Dðx; tÞdx
:
For clarity, the subscripts 3D and 1D have been included to repre-
sent the three-dimensional and one-dimensional solutions, respec-
tively. From a clinical point of view, it is believed that uniform
arterial wall drug concentrations are desirable. However, for the
purposes of this paper we do not feel it is appropriate to select a
uniformity value, that is, a value above which the profiles are
deemed not to be uniform and below which the profiles are deemed
to be uniform. Instead, we use a combination of graphical illustra-
tion and the measure discussed to conceptualize the notion of
uniformity.
4.1.1. Convection dominated system
From Fig. 3 (top) we observe that in the convection dominated
regime the P1 and P2 concentration profiles still differ very slightly
at 1 h, but by 3 h are almost identical and remain so for the rest of
the period studied. This is backed up by Table 4, where P1  P2k k is
only 1:4% after one hour, and less than 1% for the remainder of the
24 h, and indeed the remainder of the 28 days studied. Looking
more closely at Fig. 3 (top), we see that the region over which P1
and P2 noticeably differ extends only one fifth of the way into
the arterial wall. Beyond this thickness, uniform profiles are
observed within one hour. In Fig. 3 (bottom) we also display tissue
concentration profiles within abluminal-facing (y—z plane) slices
taken at three different thicknesses and at two different times.
The particular (narrow) scale has been chosen to emphasize the
differences, but clearer inspection shows that the profiles are
highly uniform in all cases. While the profiles may not look uni-
form on the particular scale chosen, the range of values on each
plot show that in fact the profiles are highly uniform in every case.
The conclusion is that in this convection dominated system, highly
uniform concentration profiles may be achieved quickly through-
out the arterial wall, despite the anisotropic nature of the
diffusivity.
4.1.2. Diffusion dominated system
From Fig. 4 (top) we observe that in the diffusion dominated
regime the concentration profiles along the trajectories P1 and P2
track each other closely, although the agreement is not as good
as the convection dominated case. After one hour the region over
which P1 and P2 differ still extends to a depth of approximately
1:5 104 m into the wall. After 3 h, this region has halved in size
to approximately 7:5 105 m and remains this thickness for the
duration of the 28 days studied. However, Table 4 demonstrates
that, while the profiles are clearly less uniform than the convection
dominated case, the maximum value of P1  P2k k is only 4:9% and
reduces to 2:8% by hour 3. In Fig. 4 (bottom) we can also see clearly
Table 3
The regimes considered.
Regime D1 D v K Pe Da1 Da2
Convection dominated 1010 m2 s1 1011 m2 s1 107m s1 105 s1 5 0:25 0:05
Diffusion dominated 1010 m2 s1 1011 m2 s1 108 m s1 105 s1 0:5 0:25 0:5
Reaction dominated 1010 m2 s1 1011 m2 s1 108 m s1 104 s1 0:5 2:5 5
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that the range of concentration values is greater in each y—z slice,
which indicates less uniform profiles than the convection domi-
nated case. The conclusion here is that in this diffusion dominated
system, near uniform concentration profiles can be maintained
across the majority of the arterial wall. Close to the lumen, the
influence of the strut geometry is most prominent, resulting in a
less uniform distribution of drug.
4.1.3. Reaction dominated system
From Fig. 5 (top) we observe that the reaction dominated regime
produces the worst levels of uniformity of the three regimes.
Similarly to the diffusion dominated case, after one hour the region
over which P1 and P2 differ still extends to a depth of approximately
1:5 104 m into the wall and this is maintained for the first 3 h.
Even after 24 h and 28 days, P1 and P2 still differ across
7:5 105 m. Despite this, from Table 4 we observe that the maxi-
mum P1  P2k k is only 6:3% and falls to below 5% by hour 3. In Fig. 5
(bottom) we can see clearly that the range of concentration values
is greater in each y—z slice compared with the convection and dif-
fusion dominated cases, which indicates that the profiles are less
uniform. Thus the conclusion here is that for this reaction domi-
nated regime, the concentrations feel the effects of the nonuniform
stent geometry to a greater degree (and for a longer duration) than
the convection and diffusion dominated cases. However, the major-
ity of the arterial wall sees near uniform concentrations for most of
the first 24 h and indeed most of the 28 days.
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Fig. 3. Convection dominated regime. Top: comparison between numerical (3D) and analytical (1D) concentration profiles at four different times. Bottom: Tissue
concentration profiles within abluminal-facing (y—z plane) slices for the convection dominated case. For each time, three slices are taken: x ¼ 0 m; x ¼ 5 105 m and
x ¼ 104 m. These have been chosen since they represent the typical thicknesses across which the profiles are least uniform.
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4.2. Comparison between three-dimensional and one-dimensional
models
In this section we focus on comparing the results of the
one-dimensional and three-dimensional models. Given the
demonstration in the previous section of the relatively uniform
profiles for each of the regimes, we focus here on the difference
between the P1 three-dimensional solution and the analytical
one-dimensional solution as given by (3.11). In order to quantify
the difference, we use a similar measure to that used in the previ-
ous section. The measure, P11D  P13D
 , essentially calculates the
difference in drug mass per unit area between the
one-dimensional and three-dimensional models, normalized by
the drug mass per unit area as calculated from the
one-dimensional model:
P11D  P13D
  ¼
R L
0
c1Dðx; tÞdx
R L
0
c3Dðx; L1; L1; tÞdxR L
0
c1Dðx; tÞdx
:
4.2.1. Convection dominated system
In the convection dominated case we see excellent agreement
between the one-dimensional and the three-dimensional models
(Fig. 3(top)). This is evidenced by the P11D  P13D
  values in
Table 5. After one hour, P11D  P13D
  is only 5:5% and drops to near
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Fig. 4. Diffusion dominated regime. Top: comparison between numerical (3D) and analytical (1D) concentration profiles at four different times. Bottom: tissue concentration
profiles within abluminal-facing (y—z plane) slices for the diffusion dominated case. For each time, three slices are taken: x ¼ 0 m; x ¼ 5 105 m and x ¼ 104 m. These have
been chosen since they represent the typical thicknesses across which the profiles are least uniform.
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negligible values by hour 3. Thus in this convection dominated
case, the one-dimensional model is adequate at predicting the
arterial wall drug distribution.
4.2.2. Diffusion dominated system
In the diffusion dominated regime there is some disagreement
between the models at early times (Fig. 4(top) and Table 5) with
a P11D  P13D
  of 11.1% at 1 h. However, by 3 h, the difference is
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Fig. 5. Reaction dominated regime. Top: comparison between numerical (3D) and analytical (1D) concentration profiles at four different times. Bottom: tissue concentration
profiles within abluminal-facing (y—z plane) slices for the reaction dominated case. For each time, three slices are taken: x ¼ 0 m; x ¼ 5 105 m and x ¼ 104 m. These have
been chosen since they represent the typical thicknesses across which the profiles are least uniform.
Table 4
Uniformity P1  P2k k for each regime. The lower the percentage value, the greater the
uniformity.
Regime 1 h (%) 3 h (%) 12 h (%) 24 h (%) 28 days (%)
kP1  P2k
Convection dominated 1.4 0.8 0.8 0.8 0.8
Diffusion dominated 4.9 2.8 2.7 2.7 2.7
Reaction dominated 6.3 4.6 4.6 4.6 4.6
Table 5
P11D  P13D
  for each regime. The lower the percentage value, the greater the
agreement between the 1D and 3D models.
Regime 1 h (%) 3 h (%) 12 h (%) 24 h (%) 28 days (%)
P11D  P13D
 
Convection dominated 5.5 0.1 0.0 0.0 0.0
Diffusion dominated 11.1 5.1 4.2 4.2 4.2
Reaction dominated 11.8 7.6 7.3 7.3 7.3
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only 5.1% and falls under 5% for the remainder of the 28 day period.
The error in using a one-dimensional model is likely to be within
the uncertainty associated with the parameter values.
4.2.3. Reaction dominated system
The reaction dominated regime shows the worst levels of agree-
ment between the one-dimensional and three-dimensional models
(Fig. 5 and Table 5), especially at early times. At 1 h, the
P11D  P13D
  is 11.8 %, but by 3 h, this reduces to 7:6%. Even after
24 h, P11D  P13D
  is still 7.3 % and remains so for the duration of
the 28 days studied. Despite this, the one-dimensional model is
still providing a reasonable representation of the full
three-dimensional model and well within the error tolerances of
the parameter values.
4.3. The effect of reducing diffusivity
In this section we examine the effect of reducing the diffusion
coefficients on the uniformity of the concentration profiles. Here
we maintain the ratio of axial/circumferential to radial diffusion
coefficient, i.e. D1=D ¼ 10. We introduce two new regimes where
the radial, axial and circumferential diffusion coefficients have all
been reduced by a factor of ten. The only two possibilities from
our range of parameter values in Table 1 are a new convection
dominated regime and a new reaction dominated regime. We find
that the effect of decreasing the diffusion coefficients is to reduce
the levels of uniformity observed at early times. This is exactly
what would be expected since the diffusion timescale in the y
and z directions is increased. For the convection dominated case,
the P1  P2k k value is still 7:9% after 3 h. However, this reduces
with time and by 12 h the difference is only 1:1%. However, unifor-
mity is significantly reduced for the reaction dominated case. After
1 h the P1  P2k k value is 40:4% and while this reduces, the value is
still 12:2% after 24 h. Comparing the one-dimensional model with
the three-dimensional model we find that the one-dimensional
approximation is good for the convection dominated case in the
latter stages of the 24 h period, but not the early stages. For the
reaction dominated case, the one-dimensional approximation
agrees with P1 values to within 12:8% by 24 h, but is a poor
approximation to the P2 values. Thus we conclude that the smaller
the value of D1 (with D1=D ¼ 10) the longer it takes for a uniform
profile to be achieved. Furthermore, the one-dimensional approxi-
mation is less acceptable, especially at predicting concentrations
along P2.
4.4. The effect of increasing anisotropy
We now examine the effect of increasing the anisotropy, i.e.
increasing the ratio D1=D. For the convection and reaction domi-
nated regimes we use the parameter values as the previous section,
except that now D1 ¼ 10
10 m2 s1 so that D1=D ¼ 100. It is not
possible to define a diffusion dominated regime with D1=D ¼ 100
that satisfies the range of parameter values in Table 1. However,
for completeness we include the diffusion dominated case
from Table 3, but increase D1 to the unrealistic value of
D1 ¼ 10
9 m2 s1. We find that the effect of increasing the
anisotropy is to result in more uniform profiles at earlier times
as well as a notable improvement in the comparison between the
one-dimensional and three-dimensional solutions.
It is also useful to consider the case where the diffusion coeffi-
cient in the axial and circumferential directions are different. We
provide one example of this here, making use of the parameter val-
ues for the convection dominated case described in the previous
section, except that we choose the diffusion coefficients in the
mutually perpendicular directions to be an order of magnitude
different. Instead of having transversely isotropic diffusion across
the y—z plane we now set the diffusion coefficient in the z direction
(Dz ¼ 10
10 m2 s1) to be a factor of ten greater than the diffusion
coefficient in the y direction (Dy ¼ 10
11 m2 s1), which in turn is
ten times greater than the diffusion coefficient in the x direction
(Dx ¼ 10
12 m2 s1). As we might have anticipated, this case pro-
vides less-uniform profiles and worse agreement between the
one-dimensional and three-dimensional models than the corre-
sponding case where Dz ¼ Dy ¼ D1 ¼ 100Dx. However, in this case
we would like to emphasize that, due to the loss of symmetry in
terms of diffusion across the y—z plane, P1 and P2 do not necessar-
ily represent the maximum and minimum drug concentrations in
the this plane.
4.5. The effect of varying strut thickness and separation
An interesting question that arises in stent design is what is the
optimal thickness and separation of struts? Of course, there are
two obvious limitations to this optimization. Firstly, the spacing
between the struts must be large enough such that an adequate
amount of plasma is exposed to the arterial wall (i.e. a solid cylin-
drical stent is not an option). Secondly, the thickness of the struts is
constrained by mechanical integrity. Over the years, stent designs
have been driven towards thinner struts in an attempt to minimize
injury (and hence in-stent restenosis). However, whilst a plethora
of different geometrical patterns have been used to ensure deliver-
ability and strength (whilst resisting shortening) the effects of such
patterns on drug distribution is under-explored. In this section we
attempt to partly address this by varying the strut thickness and
separation and observing the effect these changes have on the uni-
formity of the drug concentration and on the comparison between
the one-dimensional and three-dimensional models. For our com-
parison, we keep the amount of drug delivered per cross section of
tissue the same, but double the number of struts. The result is that
we now have four struts in the same cross section of tissue and the
thickness of the struts, 2L2, and the strut separation, 2L1, are both
halved and now take the values L2 and L1, respectively. The new
configuration is displayed in Fig. 6.
The numerical simulations were performed for the convection
dominated, diffusion dominated and reaction dominated cases
(Table 3) using the same mesh discretization as the original
geometrical configuration. From a comparison between
Figs. 3–5(top) with Figs. 7–9 it is evident that the result of reducing
the strut thickness and separation is more uniform concentration
profiles. This is backed up by the reduction in the P1  P2k k values,
as displayed in Table 6. Another important effect we observed is
the better agreement between the one-dimensional and
three-dimensional models when the strut thickness and spacing
is reduced. This is clearly visible by comparing Figs. 3–5 with
Figs. 7–9 and is also backed up by the reduction in the
P11D  P13D
  values between Tables 5 and 6.
5. Discussion
In this paper we have addressed the validity of two common
assumptions that are made in modelling the distribution of drug
in the arterial wall following stent-based delivery. Firstly, we have
derived two conditions which must be satisfied to allow us to rea-
sonably approximate the curved arterial wall geometry as a rectan-
gular geometry. These conditions depend on the ratio of the
arterial wall thickness to the arterial radius, the ratio of arterial
wall thickness to strut separation and the ratio of the radial diffu-
sion coefficient to the axial/circumferential diffusion coefficient.
This analysis validates the extensive use of this assumption in
the literature, at least for the range of parameter values considered
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here. Secondly, by comparing drug transport and distribution pre-
dicted by an idealized three-dimensional model with that of a
one-dimensional model, we have been able to show that a
one-dimensional model is adequate in certain circumstances.
Furthermore, we have verified that the anisotropic nature of diffu-
sivity in the arterial wall enhances the agreement between the
one-dimensional and three-dimensional models.
We have analysed three distinct regimes within the range of
typical parameter values considered. For the convection dominated
regime, highly uniform concentration profiles are achieved
throughout the arterial wall. This is somewhat surprising since
intuition would suggest that the high Peclet radial transport would
result in it taking longer for drug to diffuse across the
abluminal-facing plane. However, the effect of the radial
uni-directional transmural convection is actually to increase the
concentration gradients in the axial and circumferential directions
and thus increase the effective diffusivity in this plane. These
increased concentration gradients result in uniform concentration
profiles in the abluminal-facing plane being obtained more quickly
than in the case where radial diffusion dominates over convection.
The high radial Peclet number then transmits these uniform con-
centration profiles throughout the arterial wall. For the diffusion
dominated system, transport across the abluminal-facing plane is
slower and as such it takes longer for near-uniform profiles to be
achieved. Since radial transport is slowed (the timescale for trans-
port across the arterial wall is an order of magnitude slower) the
influence of the strut geometry is transmitted a small distance into
the arterial wall. When drug absorption is the significant feature,
Fig. 6. Comparison between original geometry (left) and geometry with halved strut thickness and separation (right). The cross-sectional area is kept constant.
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Fig. 7. The case of halved strut thickness and separation. Convection dominated regime.
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Fig. 8. The case of halved strut thickness and separation. Diffusion dominated regime.
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Fig. 9. The case of halved strut thickness and separation. Reaction dominated regime.
S. McGinty et al. / International Journal of Heat and Mass Transfer 90 (2015) 266–279 277
as in the reaction dominated case, the influence of the strut geom-
etry is even more evident. The reason for this lies in the fact that
high drug absorption rates reduce the transport of drug through
the arterial wall. Despite the less uniform profiles for the diffusion
and reaction dominated cases, the majority of the arterial wall sees
near uniform profiles for most of the period studied. In all of these
cases the one-dimensional model provides a good approximation
to the three-dimensional model, especially in the convection dom-
inated case and especially at later times within the first 24 h.
Generally speaking, the better the levels of uniformity observed,
the better is the one-dimensional model at replicating the results
of the three-dimensional model. It is worth emphasizing that the
degree of variability of the estimates of the parameters is substan-
tially greater than the difference between the one-dimensional and
the three-dimensional model, lending support to the hypothesis
that, for the most part, a one-dimensional model provides an
adequate description of the diffusion process.
It is interesting to assess our findings in the context of clinical
and manufacturing considerations. Clinicians suggest that uniform
drug concentration profiles are desirable. If it were the case that
drug distribution followed the pattern of the struts then large areas
of tissue would be exposed to levels of drug which are ineffective
while those areas directly behind the struts may receive toxic
levels of drug. From our analysis, we have shown that if uniform
profiles were to be required in the early hours of implantation then
convection dominated transport would be desired. Since the arte-
rial wall thickness and magnitude of the transmural convection
will be fixed for a given patient, the only parameter that can be
modified at the manufacturing stage is the drug diffusion coeffi-
cient. Thus it appears that low radial drug diffusion coefficients
are desirable, giving rise to Pe > 1. However, it has been hypothe-
sized that the magnitude of the transmural convection may be a
function of disease [24], and actually increases following stent
insertion due to the resulting damage to the endothelium. As the
endothelium heals, providing greater resistance to transport across
the wall, the convection may well decrease resulting in lower Pe
values at later times. However, it is anticipated that uniform drug
concentrations will be less important at later times when the
endothelium has healed since the drug concentrations at these
times are likely to be significantly lower than toxic values and
therapeutic levels may no longer be required. We have also
demonstrated that designing struts that are thinner and closer
together results in greater uniformity of drug concentrations more
quickly, resulting in better agreement between the
one-dimensional and three-dimensional models. Of course there
are physiological and mechanical constraints on how close
together the struts can be placed and on how thin they can be.
Thus there is a balance to be struck between reducing strut thick-
ness and separation to ensure a uniform drug distribution and
maintaining mechanical integrity and sufficient tissue exposure
to the lumen.
As we have already mentioned, many of the parameters in our
model are in fact drug-dependent. Bozsak et al. [15] studied the
transport properties of two commercial drugs, paclitaxel and siro-
limus, used to coat current drug-eluting stents. They found that
due to differences in the diffusion coefficients and binding param-
eters of these drugs, the main mechanism of transport was differ-
ent. They found that for paclitaxel the timescale for convection is
faster than that for drug binding while for sirolimus the timescale
for binding was faster than that for convection. Whilst it should be
stressed that [15] considered a more sophisticated model of bind-
ing, it is still, nonetheless, interesting to interpret their findings in
the context of this present work. If paclitaxel transport through the
arterial wall is indeed within the convection dominated regime,
then our results suggest that highly uniform drug concentrations
may be achieved rapidly throughout the arterial wall for this drug.
However, if sirolimus transport through the arterial wall is within
the reaction dominated regime then our results suggest less uni-
form profiles, with the stent strut geometry having an influence
on drug distribution close to the lumen. However, in both cases,
the majority of the arterial wall would see near-uniform concen-
tration profiles. This would suggest a one-dimensional model
may more closely replicate the three-dimensional results of
paclitaxel transport through the arterial wall.
Our results have demonstrated that the higher the value of the
axial and circumferential diffusion coefficient, D1, with D1=DP 10,
the quicker the time taken for uniform drug concentrations to be
achieved in the abluminal-facing plane, and the better the compar-
ison between the one-dimensional and three-dimensional models.
Also, perhaps counter-intuitively, we have demonstrated that the
greater the level of anisotropy, i.e. the greater the value of D1=D,
the more uniform the drug concentrations are and the better the
comparison between the one-dimensional and three-dimensional
models.
In summary, the ideal situation from a drug delivery point of
view would appear to be the manufacturing of a device with thin
struts that are close together, containing a drug that possesses fast
circumferential and axial diffusion coefficients which are much lar-
ger than the radial diffusion coefficient ðD1=D 1Þ, and satisfy
Pe > 1. Under these conditions, uniform drug concentrations are
achieved quickly and are transmitted through the arterial wall. In
this case the one-dimensional model best replicates the
three-dimensional model. In contrast, the least ideal situation from
a clinical point of view would appear to be the manufacturing of a
device with thick struts that are far apart and contain a drug that
possesses slow circumferential and axial diffusion coefficients of
the same order as the radial diffusion coefficient and satisfying
Da1 > 1 and Da2 > 1. Under these conditions, uniform drug con-
centrations are not achieved throughout the wall and this could
result in regions of toxicity and/or regions of under-exposure to
therapeutic levels of drug. A non-negligible area of highly
non-uniform drug concentrations persists close to the lumen even
after 24 h. For these reasons, in this case the one-dimensional
model is a poor representation of the three-dimensional model.
6. Limitations and applicability
We believe that it is appropriate to reiterate that a number of
simplifications have been made in this analysis. Firstly, we do
not model the release of drug from the device but instead assume
that the drug concentration may be described by an exponentially
decaying function of time with a prescribed release rate. Secondly,
we model the arterial wall as a single layer with diffusion coeffi-
cients, convection and reaction parameters that are independent
of space, concentration and time. Our justification for neglecting
the intima layer of the wall (closest to the lumen) is that it is likely
Table 6
The case of halved strut thickness and separation. Top: Uniformity ðP1  P2Þ for each
regime. The lower the percentage value, the greater the uniformity. Bottom:
ðP11D  P13D Þ for each regime. The lower the percentage value, the greater the
agreement between the 1D and 3D models.
Regime 1 h (%) 3 h (%) 12 h (%) 24 h (%) 28 days (%)
P1  P2
Convection dominated 1.0 0.7 0.7 0.7 0.7
Diffusion dominated 2.2 1.5 1.5 1.5 1.5
Reaction dominated 2.7 2.1 2.1 2.1 2.1
P11D  P13D
Convection dominated 2.7 0.1 0.1 0.1 0.1
Diffusion dominated 6.8 3.0 2.5 2.5 2.5
Reaction dominated 7.4 4.8 4.6 4.6 4.6
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to be severely damaged or removed during the stent expansion
process and we neglect the adventitia since we have previously
demonstrated that the presence of the adventitia has little effect
on the observed drug concentrations in the media where the drug
is targeted [24]. We choose our boundary conditions in such a way
that drug cannot be lost to the flowing blood in the lumen. This
may be justified by the fact that stents are now routinely coated
abluminally to reduce washout.
We also acknowledge that we do not fully model the binding of
drug to components within the arterial wall, since the focus of this
work is to study the effect of anisotropic diffusion on the unifor-
mity of drug distribution, and to make comparisons between
one-dimensional analytical and three-dimensional numerical solu-
tions. Several models of drug binding have been proposed in the
literature, but the most appropriate model for a given system
may well depend on the particular drug considered. Instead, for
the purpose of this study we assume that drug is absorbed at a pre-
scribed rate. The absorption model we consider can be shown to be
a special case of the most complex non-linear saturable binding
model that has been proposed for drug binding in the arterial wall.
Specifically, at early times (up to around 1 day), the non-linear
model is well approximated by the linear absorption model. After
this time, when the drug binding sites have become saturated, then
the transport process will be heavily influenced by the unbinding
rate: if this is sufficiently small then we may revert to either diffu-
sion or convection dominated transport.
Perhaps the most significant assumption is that the arterial
geometry is that of a rigid cylinder. In reality, this is not the case,
especially when there exists significant levels of disease.
However, to date most of the modelling in this field assumes an
idealized geometry, as we have here. It is likely that some of the
effects observed in this study may be replicated in more realistic
patient-specific geometries, at least under certain circumstances.
We would like to reiterate that the analysis applied here is not
specific to drug-eluting stents, nor drug distribution in arterial tis-
sue. For example, many of the ideas and conclusions presented in
this paper may be applied to arterial drug distribution following
delivery from drug coated balloons. Of course, the geometrical con-
figuration would differ from that presented in Fig. 1 and the expo-
nentially decaying boundary condition would require modification.
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